Document Detail


Pantoprazole reduces the size of postbanding ulcers after variceal band ligation: a randomized, controlled trial.
MedLine Citation:
PMID:  15726658     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Elective esophageal variceal ligation (EVL) is performed to decrease the risk of variceal hemorrhage. Side effects of EVL include hemorrhage, chest pain, dysphagia, and odynophagia. Because gastric acid may exacerbate postbanding ulcers and delay healing, proton pump inhibition may decrease side effects associated with EVL. The aim of this study was to assess the efficacy of pantoprazole, a proton pump inhibitor, as an adjunct to elective EVL. We performed a double-blinded, randomized, placebo-controlled trial of pantoprazole after elective EVL. Subjects in the pantoprazole arm received 40 mg pantoprazole intravenously after EVL followed by 40 mg oral pantoprazole for 9 days. Control subjects received intravenous and oral placebo. Subjects underwent upper endoscopy 10 to 14 days after banding. Primary outcomes included the size and number of ulcers and the subjects' reports of dysphagia, chest pain, and heartburn. Forty-four subjects were randomized: 42 completed the protocol. At follow-up endoscopy, the mean number of ulcers was similar in the two groups. However, the ulcers in the pantoprazole group were on average half as large as in the placebo group (37 mm(2) vs. 82 mm(2), P < .01). Chest pain, dysphagia, and heartburn scores were not significantly different. Four subjects, all in the placebo group, had adverse outcomes, including 3 who bled from postbanding ulcers and 1 with sepsis. In conclusion, subjects receiving pantoprazole after elective EVL had significantly smaller postbanding ulcers on follow-up endoscopy than subjects receiving placebo. However, the total ulcer number and patient symptoms were not different between the groups.
Authors:
Nicholas J Shaheen; Eugene Stuart; Sarah M Schmitz; Kate L Mitchell; Michael W Fried; Steven Zacks; Mark W Russo; Joseph Galanko; Roshan Shrestha
Related Documents :
3905468 - Famotidine: nocturnal administration for gastric ulcer healing. results of multicenter ...
23365148 - Ayurvedic medicine offers a good alternative to glucosamine and celecoxib in the treatm...
15139488 - Pattern of gastric emptying in functional dyspepsia. an ultrasonographic study.
12911658 - Combination therapy of ecabet sodium and cimetidine compared with cimetidine alone for ...
3905468 - Famotidine: nocturnal administration for gastric ulcer healing. results of multicenter ...
21352158 - Mental health literacy among internet users.
Publication Detail:
Type:  Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  Hepatology (Baltimore, Md.)     Volume:  41     ISSN:  0270-9139     ISO Abbreviation:  Hepatology     Publication Date:  2005 Mar 
Date Detail:
Created Date:  2005-02-28     Completed Date:  2005-03-17     Revised Date:  2007-11-14    
Medline Journal Info:
Nlm Unique ID:  8302946     Medline TA:  Hepatology     Country:  United States    
Other Details:
Languages:  eng     Pagination:  588-94     Citation Subset:  IM    
Affiliation:
Division of Gastroenterology and Hepatology, University of North Carolina School of Medicine, Chapel Hill, NC, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
2-Pyridinylmethylsulfinylbenzimidazoles
Benzimidazoles / therapeutic use*
Double-Blind Method
Esophageal and Gastric Varices / complications,  surgery*
Female
Gastrointestinal Hemorrhage / prevention & control
Humans
Ligation / adverse effects
Male
Middle Aged
Omeprazole / analogs & derivatives*,  therapeutic use*
Sulfoxides / therapeutic use*
Ulcer / prevention & control*
Grant Support
ID/Acronym/Agency:
K23DK59311-01/DK/NIDDK NIH HHS
Chemical
Reg. No./Substance:
0/2-Pyridinylmethylsulfinylbenzimidazoles; 0/Benzimidazoles; 0/Sulfoxides; 102625-70-7/pantoprazole; 73590-58-6/Omeprazole

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  No relevant effect of ursodeoxycholic acid on cytochrome P450 3A metabolism in primary biliary cirrh...
Next Document:  Variceal ligation plus nadolol compared with ligation for prophylaxis of variceal rebleeding: a mult...